Covid booster jabs leading to big business for pharma companies

The Pfizer, BioNTech and Moderna firms are expected to reap billions of dollars from Covid-19 booster shots.

The Pharmaceutical companies have together locked up over 50 billion Euro in sales of the shots just in 2021 and 2022. A growing list of governments including Germany and Israel, have decided to offer booster doses to the vulnerable to stave off the spreading Delta variant. Analysts have forecast revenue of over €5.5 billion for the Pfizer/BioNTech shot and €6.4 billion for Moderna in 2023, mostly from booster sales. Back to news Follow South East Radio on: Facebook – Instagram – Twitter – Linkedin